Publications by authors named "Michael Balestra"

Claim this Profile
D
Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity.
Kenneth Meyers, Derek A Cogan, Jennifer Burke, Raquel Arenas, Michael Balestra

Bioorg Med Chem Lett· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators.
Hui Xiong, Todd A Brugel, Michael Balestra, Dean G Brown, Kelly A Brush

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1.
Todd A Brugel, Reed W Smith, Michael Balestra, Christopher Becker, Thalia Daniels

Bioorg Med Chem Lett· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR development of a series of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as kappa opioid receptor antagonists. Part 2.
Todd A Brugel, Reed W Smith, Michael Balestra, Christopher Becker, Thalia Daniels

Bioorg Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis